propranolol has been researched along with be 2254 in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 5 (71.43) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
García-Sáinz, JA; González-Espinosa, C; Romero-Avila, MT; Torres-Márquez, ME | 1 |
Bristow, MR; Hershberger, RE; Sundberg, L; Wynn, JR | 1 |
Grady, R; Klein, DC; Mefford, IN; Namboodiri, MA; Pierce, JE; Sugden, D | 1 |
Corr, PB; Kurz, T; Wolf, RA; Ye, H | 1 |
Musters, RJ; van der Laarse, WJ; van der Meulen, ET; van Hardeveld, C | 1 |
Chen, J; Han, C; Ma, J; Yu, GS; Zhang, LF | 1 |
Buck, K; Ferger, B | 1 |
7 other study(ies) available for propranolol and be 2254
Article | Year |
---|---|
Characterization of rat white fat cell alpha 1B-adrenoceptors.
Topics: Adipose Tissue; Adrenergic alpha-Antagonists; Animals; Blotting, Northern; Epinephrine; Iodine Radioisotopes; Kinetics; Male; Membranes; Phenethylamines; Phosphatidylinositols; Propranolol; Quinazolines; Radioligand Assay; Rats; Rats, Wistar; Receptors, Adrenergic, alpha; RNA, Messenger; Stimulation, Chemical; Tetralones; Tritium | 1992 |
Mechanism of action of bucindolol in human ventricular myocardium.
Topics: Adenylyl Cyclases; Adrenergic beta-Antagonists; Binding, Competitive; Cell Membrane; Heart; Heart Ventricles; Humans; In Vitro Techniques; Iodocyanopindolol; Lymphocytes; Myocardium; Phenethylamines; Pindolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Tetralones | 1990 |
Ovine pineal alpha 1-adrenoceptors: characterization and evidence for a functional role in the regulation of serum melatonin.
Topics: Acetyltransferases; Animals; Binding, Competitive; Circadian Rhythm; In Vitro Techniques; Melatonin; Phenethylamines; Pineal Gland; Prazosin; Propranolol; Receptors, Adrenergic, alpha; Sheep; Tetralones | 1985 |
Phosphatidic acid increases in response to noradrenaline and endothelin-1 in adult rabbit ventricular myocytes.
Topics: Adrenergic alpha-Antagonists; Animals; Cells, Cultured; Dose-Response Relationship, Drug; Endothelins; Heart; Kinetics; Myocardium; Norepinephrine; Phenethylamines; Phosphatidic Acids; Phospholipase D; Propranolol; Rabbits; Stimulation, Chemical; Tetralones; Time Factors | 1994 |
Norepinephrine pretreatment attenuates Ca2+ overloading in rat trabeculae during subsequent metabolic inhibition: improved contractile recovery via an alpha 1-adrenergic, PKC-dependent signaling mechanism.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alkaloids; Animals; Benzophenanthridines; Calcium; Enzyme Inhibitors; Heart; Heart Ventricles; Ischemic Preconditioning, Myocardial; Male; Myocardial Contraction; Myocardium; Norepinephrine; Phenanthridines; Phenethylamines; Propranolol; Protein Kinase C; Rats; Rats, Wistar; Signal Transduction; Tetralones | 1997 |
Modulation of myocardial alpha 1- but not beta-adrenoceptors after 90-day tail-suspension.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atrial Function, Right; Binding Sites; Dose-Response Relationship, Drug; Hindlimb Suspension; Isoproterenol; Myocardium; Papillary Muscles; Phenethylamines; Phenylephrine; Pindolol; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta; Tetralones; Weightlessness Simulation | 1996 |
The selective alpha1 adrenoceptor antagonist HEAT reduces L-DOPA-induced dyskinesia in a rat model of Parkinson's disease.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Antiparkinson Agents; Brain; Cerebrospinal Fluid; Disease Models, Animal; Dyskinesia, Drug-Induced; Idazoxan; Levodopa; Male; Motor Activity; Oxidopamine; Parkinsonian Disorders; Plasma; Propranolol; Random Allocation; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Tetralones | 2010 |